VanderBrug Medendorp S - Search Results

1

Low-dose oral methotrexate in chronic progressive multiple sclerosis: analyses of serial MRIs.

Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Van Dyke C. Goodkin DE, et al. Among authors: vanderbrug medendorp s. Neurology. 1996 Nov;47(5):1153-7. doi: 10.1212/wnl.47.5.1153. Neurology. 1996. PMID: 8909421 Clinical Trial.

2

Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.

Goodkin DE, Rudick RA, VanderBrug Medendorp S, Greene T, Schwetz KM, Fischer J, Daughtry MM, Ross J, Van Dyke C. Goodkin DE, et al. Among authors: vanderbrug medendorp s. Online J Curr Clin Trials. 1992 Sep 25;Doc No 19:[7723 words; 89 paragraphs]. Online J Curr Clin Trials. 1992. PMID: 1343611 Clinical Trial.

3

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fischer J, Van Dyke C. Goodkin DE, et al. Among authors: vanderbrug medendorp s. Ann Neurol. 1995 Jan;37(1):30-40. doi: 10.1002/ana.410370108. Ann Neurol. 1995. PMID: 7818255 Clinical Trial.

4

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis.

Goodkin DE, Kinkel RP, Weinstock-Guttman B, VanderBrug-Medendorp S, Secic M, Gogol D, Perryman JE, Uccelli MM, Neilley L. Goodkin DE, et al. Among authors: vanderbrug medendorp s. Neurology. 1998 Jul;51(1):239-45. doi: 10.1212/wnl.51.1.239. Neurology. 1998. PMID: 9674809 Clinical Trial.

5

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J. Rudick RA, et al. Among authors: vanderbrug medendorp s. Ann Neurol. 1996 Oct;40(4):618-27. doi: 10.1002/ana.410400412. Ann Neurol. 1996. PMID: 8871582

6

Tissue plasminogen activator-assisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration: a randomized, double-masked trial.

Lewis H, VanderBrug Medendorp S. Lewis H, et al. Among authors: vanderbrug medendorp s. Ophthalmology. 1997 Nov;104(11):1847-51; discussion 1852. doi: 10.1016/s0161-6420(97)30018-9. Ophthalmology. 1997. PMID: 9373115 Clinical Trial.

7

Intracavernous injection therapy: analysis of results and complications.

Lakin MM, Montague DK, VanderBrug Medendorp S, Tesar L, Schover LR. Lakin MM, et al. Among authors: vanderbrug medendorp s. J Urol. 1990 Jun;143(6):1138-41. doi: 10.1016/s0022-5347(17)40208-4. J Urol. 1990. PMID: 2342174

8

Screening for the detection of coronary artery disease by using the exercise tolerance test in a preventive medicine population.

Dunn RL, Matzen RN, VanderBrug-Medendorp S. Dunn RL, et al. Among authors: vanderbrug medendorp s. Am J Prev Med. 1991 Sep-Oct;7(5):255-62. Am J Prev Med. 1991. PMID: 1790029

9

Survival experience following Nd:YAG laser photoresection for primary bronchogenic carcinoma.

Desai SJ, Mehta AC, VanderBrug Medendorp S, Golish JA, Ahmad M. Desai SJ, et al. Among authors: vanderbrug medendorp s. Chest. 1988 Nov;94(5):939-44. doi: 10.1378/chest.94.5.939. Chest. 1988. PMID: 2460297

10

The Ohio Bicycle Injury Study.

Ashbaugh SJ, Macknin ML, VanderBrug Medendorp S. Ashbaugh SJ, et al. Among authors: vanderbrug medendorp s. Clin Pediatr (Phila). 1995 May;34(5):256-60. doi: 10.1177/000992289503400505. Clin Pediatr (Phila). 1995. PMID: 7628167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters